NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Guangzhou Virotech Pharmaceutical Co., Ltd.

Guangzhou Virotech Pharmaceutical Co., Ltd.

Private
GuangzhouHealthcare & Life Scienceshttps://www.virot.net/

Last Round

Strategic

Nov 23, 2022

Est. Valuation

$134.27M

Total Funding Raised

$13.99M

Company Overview

Guangzhou Virotech Pharmaceutical Co., Ltd. is a biotechnology company that develops innovative oncolytic virus therapies for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

oncolytic viruscancer immunotherapybiopharmaceuticalprecision medicinecompanion diagnosticssolid tumor treatmentdrug discoveryclinical trialsbiotech R&Dviral therapycancer vaccinein vitro diagnosticsIVD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Guangzhou Virotech Pharmaceutical Co., Ltd. Comparables

Compare Guangzhou Virotech Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.

Guangzhou Virotech Pharmaceutical Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hangzhou ConVerd Co., Ltd.
88%
Wuhan Binhui Biopharmaceutical Co., Ltd.
87%
ImmVira
86%

Guangzhou Virotech Pharmaceutical Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicNov 23, 2022
Series CFeb 1, 2021

Guangzhou Virotech Pharmaceutical Co., Ltd. Investors

Notable investors and investment history

Guangzhou Virotech Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Guangzhou Virotech Pharmaceutical Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Guangzhou Virotech Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGuangzhou
Year Founded2015
Last FundingNov 23, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.